Stable expression of human kinin B1 receptor in 293 cells: Pharmacological and functional characterization

British Journal of Pharmacology

Volumn 122, Issue 2, 1997, Pages 393-399

  Bastian, S ^a   Loillier, B ^a   Paquet, J L ^a   Pruneau, D ^a  

^a Laboratoires Fournier SA   (France)

Author keywords

Binding; Calcium; Kinin B1 receptor; Phosphoinositosides cascade

Indexed keywords

KALLIDIN DERIVATIVE; KININ; PHOSPHATIDYLINOSITIDE; RECEPTOR;

AGONIST; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; EMBRYO; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYDROLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CALCIUM; CELL LINE; ENZYME ACTIVATION; HUMANS; KALLIDIN; PHOSPHOLIPASE C; RECEPTOR, BRADYKININ B1; RECEPTORS, BRADYKININ; TRANSFECTION;

EID: 0030833457     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701380     Document Type: Article

References (35)

1. BERRIDGE, M.J., DAWSON, R.M.C., DOWNES, C.P., HESLOP, J.P. & IRVINE, R.F. (1982). Lithium amplifies agonist-dependent phosphatidyl inositol responses in brain and salivary gland. Biochem. J., 206, 587-595.
2. 9-bradykinin in vitro and in vivo. Br. J. Pharmacol., 92, 257-264.
3. BRADFORD, M.M. (1976). A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 721, 248-254.
4. 2 receptors. Immunopathology, 33, 186-190.
5. CHEN, C. & OKAYAMA, H. (1987). High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7, 2745-2752.
6. CHOMCZYNSKI, P. & SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
7. 9-bradykinin. Br. J. Pharmacol., 93, 969-977.
8. 1 receptors for kinins. J. Pharmacol. Exp. Ther., 259, 997-1003.
9. DRAY, A. & PERKINS, M. (1993). Bradykinin and inflammatory pain. Trends Neurosci., 16, 99-104.
10. 2 production. Br. J. Pharmacol., 113, 389-394.
11. GOBEIL, F., PHENG, L.H. BADINI, I., NGUYEN-LE, X.K., PIZZARD, A., RIZZI, A., BLOUIN, D. & REGOLI, D. (1996). Receptors for kinins in the human isolated umbilical vein. Br. J. Pharmacol., 118, 289-294.
12. 9-bradykinin. J. Biol. Chem., 259, 9263-9268.
13. 2+ indicators with greatly improved fluorescent properties. J. Biol. Chem., 260, 3440-3450.
14. HESS, J.F., BORKOWSKI, J.A., YOUNG, G.S., STRADER, C.D. & RANSOM, R.W. (1992). Cloning and pharmacological of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun., 184, 260-268.
15. INNAMORATI, G., SADEGHI, H. & BIRNBAUMER, M. (1996). A fully active nonglycosylated V2 vasopressin receptor. Mol. Pharmacol., 50, 467-473.
16. 9-bradykinin modulates DNA synthesis, phospholipase C, and protein kinase C in cultured mesangial cells. J. Biol. Chem., 266, 21037-21043.
17. KENAKIN, T. (1993). Allotopic, noncompetitive, and irreversible antagonism. In Pharmacologic Analysis of Drug-Receptor Interaction, ed. Kenakin, T. pp. 323-343. New York: Raven Press.
18. KUSUI, T., BENYA, R.V., BATTEY, J.F. & JENSEN, R.T. (1994). Glycosylation of bombesin receptors: characterization, effect on binding, and G-protein coupling. Biochemistry, 33, 12968-12980.
19. 1 receptor for kinins. Immunopharmacology, 29, 141-147.
20. 9-bradykinin-induced increases in intracellular calcium ion concentration in single bovine tracheal smooth muscle cells. Br. J. Pharmacol., 112, 934-938.
21. 1 bradykinin receptor. J. Biol. Chem., 269, 21583-21586.
22. 8]-BK and Hoe140, in two models of persistent hyperalgesia in the rat. Pain, 53, 191-197.
23. PHAGOO, S.B., YAQOOB, M., BROWN, M.C.S. & BURGESS, G.M. (1996). Selective labelling of bradykinin receptor subtypes in W138 human lung fibroblasts. Br. J. Pharmacol., 119, 863-868.
24. PROUD, D. & KAPLAN, A.P. (1988). Kinin formation: mechanisms and role in inflammatory disorders. Annu. Rev. Immunol., 6, 49-83.
25. 1 receptor-mediated relaxation in the isolated rabbit carotid artery. Eur. J. Pharmacol., 239, 63-67.
26. 1 receptor-dependent vasoconstriction following balloon catheter injury to the rabbit carotid artery. Br. J. Pharmacol., 111, 1029-1034.
27. REGOLI, D., BARABE, J. & PARK, W.K. (1977). Receptors for bradykinin in rabbit aortae. Can. J. Physiol. Pharmacol., 55, 855-867.
28. REGOLI, D. & BARABE, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
29. + RNA. In Molecular Cloning, a Laboratory Manual, ed. Sambrook, J., Fritsch, E.F. & Maniatis, T. pp. 7.26-7.29, New-York: Cold Spring Harbor Laboratory Press.
30. SANGER, F., NIKLEN, S. & COULSON, A.R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A., 74, 5463-5467.
31. SCHNECK, K.A., HESS, J.F., STONESIFER, G.Y. & RANSOM, R.W. (1994). Bradykinin receptors in rabbit aorta smooth muscle cells in culture, Eur. J. Pharmacol. (Mol. Pharmacol. Sect.), 266, 277-282.
32. 9-bradykinin and bradykinin. J. Pharmacol. Exp. Ther., 264, 930-937.
33. 2 receptors in cultured bovine aortic endothelial cells. J. Pharmacol. Exp. Ther., 262, 729-733.
34. YANO, K., HIGASHIDA, H., INOUE, R. & NOZAWA, Y. (1984). Bradykinin-induced rapid breakdown of phosphatidylinositol 4,5-biphosphate in neuroblastoma x glioma hybrid NG108-15 cells. J. Biol. Chem., 259, 10201-10207.
35. 1 receptor. J. Pharmacol. Exp. Ther., 277, 1337-1343.